Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aroplatin and Capecitabine in Refractory Colorectal Cancer
NCT00081536Phase 2Unknown
- Sponsor
- Aronex Pharmaceuticals, Inc.
- Modality
- Lipid-based Nanoparticles, Small Molecules
01
Overview
A Phase 2 trial of liposomal NDDP in colorectal cancer (CRC), sponsored by Aronex Pharmaceuticals, Inc.. Status: unknown.
02
Drugs
liposomal NDDP
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00081536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00081536.